Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Cognitive Enhancement in Healthy Elderly People (Pro-Cog)

1 de março de 2022 atualizado por: Bar-Ilan University, Israel

According to the European Commission Special Report, till 2030 it is expected ca. 40% increase of population aged 66-79. Increasing population of elderly people in modern society has suggested that more individuals are expected to suffer from cognitive deficits, as chronological aging is usually accompanied by declined cognition, in particular memory functions.

The cognitive decline reaches medical attention for about 5-25% of the elderly population (over 65 years of age) as they suffer from Mild Cognitive Impairment (MCI). MCI is usually referred to as an intermediate phase between the expected cognitive decline of normal aging and the pathological cognitive decline linked to dementia. In recent years, a new viewpoint argues that substantial improvement in cognitive function may be possible even in older age, using appropriately designed training programs. In the current project the investigators propose a potential intervention that might delay the onset of dementia by maintaining cognitive performance in general and improving in MCI in particular.

The current approach is to employ cognitive enhancement protocols, such as the combination of non-invasive, low intensity electrical stimulation and memory training aiming to preserve and ultimately improve cognitive abilities in MCI and healthy elderly.

Visão geral do estudo

Descrição detalhada

Aging is associated with several physiological changes that affect global functioning, daily activity and quality of life. For instance, cognitive functions progressively decline during normal aging, as evidenced by decreased episodic memory and working memory (WM) performance.

The above mentioned cognitive decline reaches medical attention for about 5-25% of the elderly population (over 65 years of age) as they suffer from Mild Cognitive Impairment (MCI). MCI is usually referred to as an intermediate phase between the expected cognitive decline of normal aging and the pathological cognitive decline linked to dementia. Around 46% of people with MCI develop dementia within three years, compared to 3% of the age-matched population. According to Peterson's initial definition (Petersen, 2004), The selected technique to improve cognition as the investigators propose here is transcranial non invasive brain stimulation (TES). The investigators will employ a couple of these techniques of neuromodulation that have proven to influence performance in different cognitive domains. Here the investigators propose to combine the investigators' expertise and to investigate the effects on cognition and health of brain stimulation-based treatment in MCI patients compared to matched healthy controls, combine it with cognitive training and explore the longer term effects of the intervention.

Objectives. The main objective of the proposed research is to explore the potential intervention based on non-invasive brain stimulation and cognitive training to improve cognition in the elderly. In particular the investigators aim to explore:

  1. The immediate efficacy of various stimulation protocols with cognitive training on cognitive improvement in the elderly.
  2. The long term effect of a selected stimulation protocol on MCI improvement in the elderly.

According to a large controlled study on cognitive stimulation for people with MCI, the treatment proved effective in improving the functioning in several cognitive areas compared to a control group (Ball et al., 2002).The cognitive training in this study included a computerized training, which is more enjoyable and effective than pencil-and paper training due to its immediate feedback and engaging nature. In their systematic review of 26 studies on computerized cognitive training (CCT) for older people with known MCI, Hill et al. (2016) concluded that CCT is an efficient tool for cognitive enhancement in older people with MCI. The overall effect size on cognition score was moderate (Hedges' g=0.35); a large significant effect size on working memory; and there were moderate significant effect sizes for specific cognitive domains, such as verbal memory, non-verbal learning, attention and on psychological functioning measures. In contrast, and consistent with findings of previous CCT meta-analysis (Motter, Pimontel et al., 2016), there were insignificant results regarding executive functions, processing speed and non-verbal memory. The results on dementia patients, as opposed to MCI ones, were less optimistic: there was only a small but statistically significant effect size of the overall efficacy of the CCT on cognition enhancement.

The researchers have previous works that revealed an enhanced training effect when it was combined with non-invasive brain stimulation, for example better cognitive control following training combined with Transcranial direct current stimulation (tDCS) compared to training alone (Ditye et al., 2012).

Transcranial direct current stimulation (tDCS) is a safe, low-cost, non-invasive neurophysiological technique that consists in the application of mild (1-2 milliampere (mA)) electrical current on the scalp (Jacobson et al., 2012).

There is growing evidence that tDCS, combined with cognitive stimulation, improves cognitive functioning among healthy adult subjects. Specifically, tDCS to the prefrontal cortex has been proved effective. Anodal stimulation of the left dorsolateral prefrontal cortex (DLPFC) increases the performance on a working memory task in young healthy adults. In a combined treatment of behavioral training and tDCS stimulation of ten sessions for 10 days, healthy elderly subjects increased working memory skills for up to 28 days (Park et al., 2014).

tDCS has also been proved efficient for people with Alzheimer's Disease (AD) or other types of dementia. In one study, anodal tDCS was applied to both hemispheres of the temporal cortex in 30 minutes sessions for five successive days. Results showed a significant improvement in a visual recognition memory task. tDCS anodal stimulation of the Broca's region within the left inferiorfrontal gyrus (IFG) had some positive effects on verbal fluency among patients with MCI in a double-blind, crossover, sham-controlled stimulation study. Additional brain imaging analysis of these results indicated that there was also a reduction of compensatory upregulated activity within the frontal cortices. Manenti et al. (2016) have used anodal tDCS combined with physical therapies in MCI patients with Parkinson's disease (PD). Following daily administration of 2 mA stimulation for two weeks, subjects have improved their PD Cognitive Rating Scale scores and their verbal fluency test, in comparison with the sham control group.

The efficacy of using tDCS in combination with cognitive training is yet controversial. A study on AD patients which used anodal tDCS to stimulate the left DLPFC in a name-face association learning task, found no additional effect to the tDCS stimulation beyond that of the behavioral training. In contrast to these findings, in a study of healthy subjects, the combination of tDCS stimulation and simultaneous cognitive behavioral training has been proved more effective than tDCS stimulation to the left DLPFC by itself (Martin, Liu, Alonzo et al., 2015).

In a recent study (André et al., 2016), four sessions of anodal tDCS stimulation over the left DLPFC, in combination with different cognitive tasks, were applied to 21 patients with mild vascular dementia. There was a significant improvement up to two weeks later in visual short term memory (in a pictures naming task), verbal working memory (2-back task) and executive control (go/no go task) in the anodal stimulation group, Yet, there are still some considerable limitations to the research on tDCS effects on cognition and to its clinical applications. For instance, choosing the target area or network is, of course, critical. Various target areas have been used in different studies: frontal lobe, especially the DLPFC and the IFG, are natural candidates. Few studies have targeted the inferior parietal lobe, which might require further research.

To overcome some of the problems the investigators will test another brain stimulation technique, transcranial alternating current stimulation (tACS) where promising previous results suggest that tACS over prefrontal areas might be a better tool to improve cognitive functions in the elderly. tACS, a specific subtype of Non-invasive Brain Stimulation methods (NIBS), is based on the application of low-intensity electrical currents oscillating sinusoidally at a predetermined frequency (Antal et al., 2008). TACS-mediated physiological and behavioral changes seems to be frequency-dependent, thus, tACS could interact with the on-going brain activity through cortical oscillatory entrainment.

Since episodic memory decline is one of the most important markers of MCI, the investigators will test brain stimulation protocols that were found to affect different types of memory performance. Possible effects of transcranially applied oscillating currents on memory functions have been investigated on humans by using transcranial Slow Oscillation Stimulation (SO-tDCS; i.e., anodal transcranial direct current stimulation oscillating at 0.75 Hz in a trapezoid waveform-fashion, applied bi-frontally) in combination with on-line EEG recording during slow wave sleep (Marshall et al., 2006). Ripple-range oscillations in the hippocampus have also been associated with declarative memory consolidation. The co-PI, Prof. Antal reported that bilateral 140 Hz tACS over both DLPFC during encoding may have a positive effect on the consolidation of declarative material (Ambrus et al., 2015). Novel cross-frequency protocols (theta-gamma coupling) of tACS affected spatial working memory performance in humans: enhancement of working memory performance and increase of global neocortical connectivity were observed when bursts of high gamma oscillations (80-100 Hz) coincided with the peaks of the theta waves, whereas superimposition on the trough of the theta wave and low gamma frequency protocols were ineffective.

In sum, evidence from recent studies portray a promising picture of this new line of research, suggesting that non-invasive brain stimulation techniques, in general, and tDCS and tACS, in particular, may be used to ameliorate cognitive dysfunction in patients in pre-dementia. Though prospects seem promising, the mixed results and inconclusive findings of several studies call for cautious. Hopefully, the proposed research will narrow the gap between theoretical knowledge and the clinical applicability of the findings for the sake of a treatment that can truly affect many people's lives.

The current approach is to employ cognitive enhancement tools aiming to develop effective protocols that will preserve (and ultimately improve) cognitive abilities in MCI and healthy elderly. The main method are non-invasive brain stimulation tools, tDCS and tACS, combined with computer-based cognitive training in a multiple session design.

Patient Registries:

Each subject is met by the experimenters (PhD students) for 16 individual meetings. The baseline measurements and cognitive evaluation that is manually conducted by the experimenters is inserted and saved in local Excel files. The subjects' performance in the computerized games (the cognitive training) is automatically saved on the lab's computer.

Quality assurance: the completeness and accuracy of the training log files is checked after every session.

Standard Operating Procedures - a paper file is prepared for each subject to keep background and contact details, printed records of the subjects' performance in the memory evaluation tests (at baseline, immediately after completing the intervention, and 3 months after completing the intervention).

Sample size assessment: The sample size was a priori calculated using More Power software (Campbell & Thompson, 2012) based on the effect size reported for memory enhancement by transcranial electrical stimulation by Jacobson et al. (2012) (d = 0.49). This established that with a α = 0.05, power = 0.95, 60 participants are necessary to detect a moderate-large effect.

Statistical analysis plan: data will be analyzed with IBM Statistical Package for Windows, version 23 (IBM Corp., Armonk, N.Y., USA). The main analysis is a mixed design analysis that compares the experimental conditions (between subject factors) regarding their effect on memory performance in 2 episodic memory tests and 3 time points (within subjects variables). The cognitive status at baseline will serve as a covariate (the baseline scores). In addition, the investigators plan hierarchical regression to check how ongoing scores in the cognitive training predict episodic memory score at the end of the intervention.

Tipo de estudo

Intervencional

Inscrição (Antecipado)

120

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

55 anos a 75 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

normal or corrected-to-normal vision good general health independent living MoCa score of at least 24 -

Exclusion Criteria:

A history of acute or chronic neurological illness, heart disease, metabolic disorders, vascular disorders psychiatric disorder. epilepsy metal implants

-

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição fatorial
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: tDCS over the left DLPFC with adaptive memory game
The stimulation will be carried out using a battery-powered mobile device made by "Neurocon" with two 5 x 5 cm electrodes The anodal electrode will be positioned above the F3 region of a standard EEG cap that is parallel to the cortical DLPFC region. The return electrode will be placed over the right eyebrow. The electrodes will remain on the subjects head for 50 minutes - the entire duration of the session. 1mA stimulation will be given for 15 minutes, then a 20-minute break and again 15 minutes of 1 mA stimulation. This protocol has been shown to improve the duration of the stimulus effect (Monte-Silva et al., 2013).
This intervention is described in arms 1 and 3.
Comparador de Placebo: Sham tDCS over the left DLPFC with adaptive memory game
As above but current will be operated for 1 minute - 30 seconds ramp up to 1 mA and 30 seconds ramp-down to initiate similar sensations to real stimulation. The electrodes will stay on the subjects heads for 50 minutes, similar to the active tDCS arm.
This intervention is described in arms 2 and 4.
Comparador Ativo: tACS over the left DLPFC at theta-gamma coupling with adaptive memory game
As above but stimulation method will be employed at 2mA intensity for 20 minutes at theta-gamma coupling using a laplacian montage (Alekseichuk et al., 2016).
This intervention is described in arms 1 and 3.
Comparador de Placebo: Sham tACS over the left DLPFC at theta-gamma coupling with adaptive memory game
As above but current will be operated for 1 minute - 30 seconds ramp up to 1 mA and 30 seconds ramp-down to initiate similar sensations to real stimulation. The electrodes will stay on the subjects heads for 20 minutes, similar to the active tACS arm.
This intervention is described in arms 2 and 4.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Visual episodic memory of word pairs learning test (Marshall et al., 2004)
Prazo: Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment
Number of correctly recalled word pairs
Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment
Ray auditory verbal learning test (episodic memory) includes immediate recall, and after time (Carlesimo et al., 1996),
Prazo: Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment
Number of correctly recalled items
Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Logical Memory Test 1 (Craft et al., 2000; Wechsler, 2008)
Prazo: Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment
Number of correctly recalled items
Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment
Montreal questionnaire for Cognitive Assessment (MoCA, Nasreddine et al., 2005)
Prazo: Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment
Score at the MoCA test
Change from baseline (before treatment) to immediately after treatment (6 weeks) and 3 months after end of treatment

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Michal Lavidor, Prof., Bar Ilan University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de setembro de 2020

Conclusão Primária (Antecipado)

30 de outubro de 2022

Conclusão do estudo (Antecipado)

30 de outubro de 2023

Datas de inscrição no estudo

Enviado pela primeira vez

2 de agosto de 2021

Enviado pela primeira vez que atendeu aos critérios de CQ

2 de agosto de 2021

Primeira postagem (Real)

9 de agosto de 2021

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de março de 2022

Última atualização enviada que atendeu aos critérios de controle de qualidade

1 de março de 2022

Última verificação

1 de fevereiro de 2022

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 04102020

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Não

Descrição do plano IPD

The investigators will generate big data files due to 16 meetings with all 120 participants. There is not much point in sharing these mega-files, rather the investigators can share the final groups averages to measure memory change in the 4 experimental group

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

3
Se inscrever